SIMILASAN Toux irritative glob 15 g

7680513400448 CH-51340 20.01.1.
SIMILASAN Toux irritative glob 15 g
SIMILASAN Toux irritative glob 15 g
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5134001
CPT
-
Packaging group
15
Unit
g
Composition
drosera (HAB) D3 6.000 mg, drosera (HAB) D6 2.000 mg, drosera (HAB) D12 2.000 mg, calcii carbonas, xylitolum, ad globulos pro 1 g, corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Reizhusten, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/01/2026
Patient information leaflet
Français
21/01/2026
Patient information leaflet
Italien
21/01/2026

Detailed composition

Substance Quantity Type Category
drosera (HAB)
6.0 MG Substance Wirkstoff (Principe actif)
drosera (HAB)
2.0 MG Substance Wirkstoff (Principe actif)
drosera (HAB)
2.0 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
51340
Drug name
Similasan Reizhusten, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
17/10/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei trockenem Husten mit Schmerzen hinter dem Brustbein; Reizhusten, Kitzelhusten mit Brechreiz; Hustenanfällen

Packaging details

Description (FR)
SIMILASAN Toux irritative glob 15 g
Description (DE)
SIMILASAN Reizhusten Glob 15 g
Market launch
17/10/1991
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data